Evidence map›Paper›PMID 27551666›Full record

ArticleNeuroImage. Clinical2016

PREVAIL: Predicting Recovery through Estimation and Visualization of Active and Incident Lesions.

Jordan D Dworkin, Elizabeth M Sweeney, Matthew K Schindler, Salim Chahin, Daniel S Reich, Russell T Shinohara

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jordan D DworkinDepartment of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.
Elizabeth M SweeneyDepartment of Biostatistics, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, United States.
Matthew K SchindlerTranslational Neuroradiology Unit, Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disease and Stroke, National Institute of Health, Bethesda, MD 20892, United States.
Salim ChahinMultiple Sclerosis Division of the Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.
Daniel S ReichDepartment of Biostatistics, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, United States; Translational Neuroradiology Unit, Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disease and Stroke, National Institute of Health, Bethesda, MD 20892, United States.
Russell T ShinoharaDepartment of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.
University of Pennsylvania · USJohns Hopkins University · USNational Institute of Neurological Disorders and Stroke · US

Funding

Multimodal MRI in Multiple SclerosisZIANS003119 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI REICH, DANIEL · 2010 to 2025
$53.4M
EPIDEMIOLOGY AND BIOSTATISTICS OF AGINGT32AG000247 · NIA · JOHNS HOPKINS UNIVERSITY · PI Karen J. Bandeen-Roche · 1996 to 2026
$13.2M
Statistical methods for large and complex databases of ultra-high-dimensionalR01NS085211 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI SHINOHARA, RUSSELL TAKESHI · 2013 to 2017
$1.8M
Spatiotemporal Modeling of MRI Brain Lesion Trajectories of Biomarker DiscoveryR21NS093349 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI ELOYAN, ANI, SHINOHARA, RUSSELL TAKESHI · 2016 to 2017
$454k
NIA NIH HHS T32 AG000247NINDS NIH HHS R01 NS085211NINDS NIH HHS R21 NS093349
6 · The paper itself

Abstract

objectiveThe goal of this study was to develop a model that integrates imaging and clinical information observed at lesion incidence for predicting the recovery of white matter lesions in multiple sclerosis (MS) patients.

methodsDemographic, clinical, and magnetic resonance imaging (MRI) data were obtained from 60 subjects with MS as part of a natural history study at the National Institute of Neurological Disorders and Stroke. A total of 401 lesions met the inclusion criteria and were used in the study. Imaging features were extracted from the intensity-normalized T1-weighted (T1w) and T2-weighted sequences as well as magnetization transfer ratio (MTR) sequence acquired at lesion incidence. T1w and MTR signatures were also extracted from images acquired one-year post-incidence. Imaging features were integrated with clinical and demographic data observed at lesion incidence to create statistical prediction models for long-term damage within the lesion. VALIDATION: The performance of the T1w and MTR predictions was assessed in two ways: first, the predictive accuracy was measured quantitatively using leave-one-lesion-out cross-validated (CV) mean-squared predictive error. Then, to assess the prediction performance from the perspective of expert clinicians, three board-certified MS clinicians were asked to individually score how similar the CV model-predicted one-year appearance was to the true one-year appearance for a random sample of 100 lesions.

resultsThe cross-validated root-mean-square predictive error was 0.95 for normalized T1w and 0.064 for MTR, compared to the estimated measurement errors of 0.48 and 0.078 respectively. The three expert raters agreed that T1w and MTR predictions closely resembled the true one-year follow-up appearance of the lesions in both degree and pattern of recovery within lesions.

conclusionThis study demonstrates that by using only information from a single visit at incidence, we can predict how a new lesion will recover using relatively simple statistical techniques. The potential to visualize the likely course of recovery has implications for clinical decision-making, as well as trial enrichment.

Indexed as

Disease ProgressionAdolescentAdultBrainFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMultiple SclerosisWhite MatterYoung AdultLesionMRIMultiple sclerosisNeuroimagingPrediction

Identifiers

PMID27551666
PMCPMC4983640
OpenAlexW2480860902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.